55
Lagevrio (Molnupiravir) Approved for Mild-to-Moderate COVID-19 Treatment: A Game Changer?
The FDA has approved Lagevrio (molnupiravir) 200mg C for treating mild-to-moderate COVID-19 in high-risk adults. This antiviral works by stopping the virus from replicating, potentially redu…
7 comments
384 views